This inventor holds 1 USPTO granted patent. Top assignees: Harvard College, The General Hospital Corporation. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,075 
1 out of 3,073 
Years Active: 1997
Title: Emily Kim - Innovator in Cell Death Protein Research
Introduction
Emily Kim is a prominent inventor based in Chestnut Hill, MA (US). She has made significant contributions to the field of cellular biology, particularly in the study of apoptosis. Her innovative work has led to the development of a unique protein that plays a crucial role in cell death mechanisms.
Latest Patents
Emily Kim holds a patent for a protein designated as RIP. This protein contains a death domain at its carboxy terminus and a kinase domain at its amino terminus. RIP interacts with the Fas/APO-1 intracellular domain and the TNFR1 intracellular domain. When expressed in transformed host cells, recombinant RIP promotes apoptosis. Additionally, her patent includes DNA molecules encoding RIP, anti-RIP antibodies, and screening methods for discovering inhibitors of RIP-dependent apoptosis. She has 1 patent to her name.
Career Highlights
Throughout her career, Emily has worked with esteemed institutions such as The General Hospital Corporation and Harvard College. Her research has been pivotal in advancing our understanding of cell death and its implications in various diseases.
Collaborations
Emily has collaborated with notable scientists, including Brian Seed and Tae-Ho Lee, to further her research in the field.
Conclusion
Emily Kim's innovative work in cell death protein research has made a lasting impact on the scientific community. Her contributions continue to inspire future research in apoptosis and related fields.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile